Cogent Biosciences, Inc. (COGT)
NASDAQ · Healthcare
Cogent Biosciences, Inc. EBITDA 2017–2020
Cogent Biosciences, Inc. annual/quarterly ebitda history and growth rate from 2017 to 2020. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Cogent Biosciences, Inc. ebitda for the quarter ending March 31, 2020 was -5.8 M, a 49.21% decrease year-over-year.
- Cogent Biosciences, Inc. annual ebitda for 2020 was -81.5 M, a 163.81% increase from 2019.
- Cogent Biosciences, Inc. annual ebitda for 2019 was -30.9 M, a 10.95% decrease from 2018.
- Cogent Biosciences, Inc. annual ebitda for 2018 was -34.7 M, a 38.84% increase from 2017.
- Cogent Biosciences, Inc. annual ebitda for 2017 was -25.0 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cogent Biosciences, Inc. EBITDA — FAQ
Cogent Biosciences, Inc. (COGT) ebitda over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see COGT's ebitda history?
The chart and table above show Cogent Biosciences, Inc.'s ebitda by year and by quarter, including the growth rate.